As of Thursday close, Privia Health Group Inc.’s (NASDAQ:PRVA) stock was up $1.98, moving up 10.57 percent to $20.72. The average number of shares traded per day over the past five days has been 811,360 shares. 1 time new highs have been achieved over the past 5 days, with a -$2.26 fall in that time frame. In the last twenty days, the average volume was 609,965, while in the previous 50 days, it was 750,188.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '22.
Small-cap Uranium stocks are booming in 2022! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here. .
Since last month, PRVA stock retreated -26.34%. Shares of the company fell to $17.99 on 05/12/22, the lowest level in the past month. A 52-week high of $50.77 was reached on 04/14/22 after having rallying from a 52-week low of $18.51. Since the beginning of this year, PRVA’s stock price has dropped by -19.91% or -$5.15, and marked a new high 7 times. However, the stock has declined by -59.19% since its 52-week high.
Privia Health Group Inc. (PRVA) last reported insider trading activity 23 days ago on Apr 20. Mehrotra Parth, the President and COO of the company, disposed of 20,000 shares for $27.93 on Apr 20. It resulted in a $558,600 divestment by the insider. Bartrum Thomas sold 10,000 shares at an average price of $27.93 on Apr 20. The insider now owns 27,391 shares following the transaction. On Mar 28, President and COO Mehrotra Parth sold 20,000 shares at $25.09 apiece. The transaction was valued at $501,800.
In the three months ended September 29, Privia Health Group Inc.’s quick ratio stood at 2.30, while its current ratio was 2.30, showing that the company is able to pay off its debt. According to company report, the long-term debt-to-equity ratio for the quarter ending September 29 was 0.07, and the total debt-to-equity ratio was 0.08. On the profitability front, the trailing twelve-month gross margin is 6.60% percent. In the year ended September 29, operating margins totaled -22.50%. Based on annual data, PRVA earned $63.66 million in gross profit and brought in $966.22 million in revenue.
A company’s management is another factor that investors consider when determining the profitability of an investment. In the past year, return on investment (ROI) was -41.30%. Return on equity (ROE) for the past 12 months was -54.40%.
In Privia Health Group Inc.’s quarter-end financial report for September 29, it reported total debt of $31.69 million. According to the earnings report, the company had a higher net income in the recent quarter than it did in the previous quarter. PRVA’s revenue rose 100.0% to $251.52 million during the quarter, while net income inched up to $275.33 million. While analysts expected Privia Health Group Inc. to report -$0.11 quarterly earnings, the actual figure was -$0.09 per share, beating the consensus estimate by 18.20%. During the quarter, the company generated -$18.2 million in EBITDA. The liabilities of Privia Health Group Inc. were 236.19 million at the end of its most recent quarter ended September 29, and its total debt was $42.57 million. The value of shareholders’ equity is $108.17 million.
This quick technical analysis looks at Privia Health Group Inc.’s (PRVA) price momentum. With a historical volatility rate of 98.35%, the RSI 9-day stood at 38.89% on 12 May.
With respect to its five-day moving average, the current Privia Health Group Inc. price is down by -9.83% percent or -$2.26. At present, PRVA shares trade -27.14% below its 20-day simple moving average and -12.09% percent below its 100-day simple moving average. However, the stock is currently trading approximately -18.90% below its SMA50 and -52.28% below its SMA200.
Stochastic coefficient K was 16.49% and Stochastic coefficient D was 10.92%, while ATR was 2.02. Given the Stochastic reading of 36.02% for the 14-day period, the RSI (14) reading has been calculated as 39.12%. As of today, the MACD Oscillator reading stands at -1.97, while the 14-day reading stands at -2.81.
BofA Securities launched its rating on Privia Health Group Inc. (NASDAQ: PRVA) to a Buy in a note to investors on May 03, 2022. Privia Health Group Inc. (PRVA) has been rated Buy by analysts. According to 0 brokerage firms, PRVA is a sell, and 0 firms recommend it is a Hold. There are 0 analysts who say the stock is underweight. A total of 0 analysts rate Privia Health Group Inc. stock as buy, with 13 recommending it as overweight.
With a median target price of $35.00, the current consensus forecast for the stock is $27.00 – $45.00. Based on these forecasts, analysts predict Privia Health Group Inc. (PRVA) will achieve an average price target of $35.08.